TL;DR
- •Klonopin (clonazepam) and Xanax (alprazolam) are both benzodiazepines, but their half-lives differ dramatically — Klonopin ~30-40 hours, Xanax ~11 hours. This is the most important difference between them.
- •Xanax's short half-life produces faster onset and faster offset — useful for acute panic but with steeper rebound anxiety, more interdose withdrawal, and higher abuse potential.
- •Klonopin's long half-life produces smoother coverage with less interdose breakthrough and lower abuse potential — generally preferred for chronic anxiety management when a benzodiazepine is appropriate.
- •Both carry dependence risk with daily use beyond 2-4 weeks and require careful tapering when discontinued. Withdrawal can include rebound anxiety, insomnia, autonomic instability, and rare but serious seizures.
- •Modern guidelines position benzodiazepines as short-term or as-needed agents rather than chronic first-line treatments — SSRIs/SNRIs are first-line for chronic anxiety with much better long-term safety profiles.
- •For treatment-resistant anxiety despite SSRI/SNRI trials, ketamine's NMDA mechanism provides a non-benzo, non-dependence-forming alternative with rapid onset.
Side by side
Klonopin
Clonazepam
Long-acting benzodiazepine
What it treats
Panic disorder, Seizure disorders, Off-label: generalized anxiety, REM sleep behavior disorder
Mechanism
Enhances GABA-A receptor activity producing anxiolytic, anticonvulsant, sedative, and muscle-relaxant effects. Long half-life (~30-40 hours) provides smooth coverage with less interdose fluctuation than shorter-acting benzos.
Strengths
- •Long half-life provides smooth daily coverage
- •Lower interdose rebound and breakthrough anxiety
- •Generally lower abuse potential than alprazolam
- •Smoother taper when discontinuing
Limitations
- •Accumulates with repeated dosing — can produce next-day sedation
- •Slower onset than alprazolam — less suitable for acute panic
- •Long half-life means side effects (sedation, cognitive slowing) take days to clear
- •Still carries dependence risk with chronic use
Xanax
Alprazolam
Short-acting benzodiazepine
What it treats
Panic disorder, Generalized anxiety disorder, Off-label: short-term acute anxiety
Mechanism
Enhances GABA-A receptor activity with faster onset and shorter half-life (~11 hours) than clonazepam. Quick relief profile makes it useful for acute panic but with steeper rebound between doses.
Strengths
- •Fast onset — relief within 15-30 minutes
- •Useful for acute panic attacks or anticipatory anxiety
- •Short duration means it clears faster
- •Familiar to patients and broadly available
Limitations
- •Highest abuse potential of common benzodiazepines
- •Interdose withdrawal — rebound anxiety between doses with chronic dosing
- •Steeper withdrawal syndrome on discontinuation
- •Short half-life means missed doses produce withdrawal symptoms quickly
Which one for your situation?
If:
Patient needs benzodiazepine for chronic daily use (when appropriate)
Verdict:
Klonopin — long half-life produces smoother coverage with lower abuse risk
If:
Patient needs as-needed benzodiazepine for occasional acute panic
Verdict:
Xanax — fast onset, useful for episodic situations
If:
History of substance use disorder
Verdict:
Neither ideal — if benzo necessary, Klonopin's lower abuse potential is the safer choice
If:
Patient is currently on Xanax with interdose withdrawal or escalating dose
Verdict:
Switch to Klonopin (or other long-acting benzo) for smoother coverage and easier taper
If:
Coming off a benzodiazepine
Verdict:
Either can be tapered; Klonopin's long half-life makes the taper smoother. Coordinate with prescriber — withdrawal can be serious
If:
Chronic anxiety beyond a few weeks
Verdict:
SSRI or SNRI first-line, not benzodiazepines — benzos are best reserved for short-term or as-needed use
Where ketamine fits
Ketamine is not a substitute for acute benzodiazepine use, but for chronic anxiety where SSRIs/SNRIs haven't produced sufficient response, ketamine's NMDA mechanism offers a non-benzo, non-dependence-forming option with rapid onset. Many patients on chronic benzodiazepines successfully reduce their dose after ketamine response.
Xanax: 15-30 minutes for acute relief. Klonopin: 30-60 minutes, longer-lasting. Ketamine: hours for mood/anxiety response, with effects building over multiple sessions for chronic relief.
5-minute screening · Reviewed by a board-certified physician · FL & NJ
Frequently asked
Is Klonopin or Xanax stronger?
Different rather than "stronger." Klonopin's long half-life produces sustained coverage; Xanax's short half-life produces faster onset and faster offset. Milligram-for-milligram, Xanax has a higher peak effect per dose but doesn't last as long. Most patients find Klonopin "feels less intense" because it builds slowly rather than spiking and crashing like Xanax.
Which is more addictive?
Xanax. Short half-life with sharp peaks and troughs produces a more reinforcing pattern that's associated with higher abuse potential. Klonopin's longer half-life produces smoother effects with less of the "rush-and-crash" pattern. Both carry dependence risk with chronic use; neither is a long-term anxiety solution.
Can I switch from Xanax to Klonopin?
Yes — this is a common clinical maneuver for patients on chronic Xanax who are experiencing interdose withdrawal, dose escalation, or who want to eventually taper off. The cross-titration involves overlapping the two for a period while reducing Xanax and increasing Klonopin to equivalent doses. Coordinate with your prescriber — DIY switches risk withdrawal symptoms.
How long can I stay on a benzodiazepine?
Current guidelines recommend short-term use (2-4 weeks) for acute anxiety/insomnia. Chronic daily use beyond a few weeks creates physical dependence and tolerance. Some patients use benzodiazepines safely for years under careful monitoring, but the default modern approach is benzos for acute or as-needed use, SSRIs/SNRIs (or non-benzo alternatives) for chronic anxiety. Cessation after long-term use requires a slow taper to avoid serious withdrawal.
What if SSRIs and benzodiazepines aren't enough for my anxiety?
After SSRI/SNRI trials without sufficient relief, options include adding buspirone (non-addictive anxiolytic), pregabalin/gabapentin (anxiolytic effect without benzo dependence), CBT (cognitive-behavioral therapy with strong evidence for anxiety), TMS, or ketamine. Ketamine specifically has emerging evidence in treatment-resistant anxiety alongside depression and offers rapid onset without dependence formation.
References
- Guaiana G et al. 2023, Cochrane Database of Systematic Reviews. Network meta-analysis of pharmacological treatments for panic disorder — addresses comparative efficacy of benzodiazepines including alprazolam and clonazepam. PMID 38014714
- Figg JW et al. 2026, Annals of General Psychiatry. Comprehensive review of therapeutic vs harms balance for benzodiazepines in modern practice. PMID 41622184
- Samardic J et al. 2026, Healthcare. Evidence-based prescribing strategies for benzodiazepines including half-life-driven choice between agents. PMID 42194483
- Kleykamp BA et al. 2026, Journal of Addiction Medicine. Review of evidence and limitations in benzodiazepine tapering protocols. PMID 42160770